Cytotoxic rhamnolipid micelles drive acute virulence in Pseudomonas aeruginosa .
Qi XuDonghoon KangMatthew D MeyerChristopher L PenningtonCitrupa GopalJeffrey W SchertzerNatalia V KirienkoPublished in: Infection and immunity (2024)
Pseudomonas aeruginosa is an opportunistic human pathogen that has developed multi- or even pan-drug resistance toward most frontline and last resort antibiotics, leading to increasing frequency of infections and deaths among hospitalized patients, especially those with compromised immune systems. Further complicating treatment, P. aeruginosa produces numerous virulence factors that contribute to host tissue damage and immune evasion, promoting bacterial colonization and pathogenesis. In this study, we demonstrate the importance of rhamnolipid production in host-pathogen interactions. Secreted rhamnolipids form micelles that exhibited highly acute toxicity toward murine macrophages, rupturing the plasma membrane and causing organellar membrane damage within minutes of exposure. While rhamnolipid micelles (RMs) were particularly toxic to macrophages, they also caused membrane damage in human lung epithelial cells, red blood cells, Gram-positive bacteria, and even noncellular models like giant plasma membrane vesicles. Most importantly, rhamnolipid production strongly correlated with P. aeruginosa virulence against murine macrophages in various panels of clinical isolates. Altogether, our findings suggest that rhamnolipid micelles are highly cytotoxic virulence factors that drive acute cellular damage and immune evasion during P. aeruginosa infections.
Keyphrases
- pseudomonas aeruginosa
- biofilm formation
- drug delivery
- liver failure
- cystic fibrosis
- oxidative stress
- drug release
- escherichia coli
- respiratory failure
- cancer therapy
- staphylococcus aureus
- acinetobacter baumannii
- candida albicans
- antimicrobial resistance
- red blood cell
- aortic dissection
- hyaluronic acid
- pluripotent stem cells
- induced pluripotent stem cells
- smoking cessation